Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,746.50
Bid: 1,742.50
Ask: 1,743.00
Change: 6.50 (0.37%)
Spread: 0.50 (0.029%)
Open: 1,730.00
High: 1,746.50
Low: 1,729.00
Prev. Close: 1,740.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

Wed, 01st Nov 2023 16:52

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Next flourished after raising profit guidance once again, but Aston Martin Lagonda went into reverse after cutting sales forecasts for its DB12 sports car.

The FTSE 100 index closed up 20.71 points, 0.3%, at 7,342.43. The FTSE 250 ended up 102.84 points, 0.6%, at 17,185.89, and the AIM All-Share closed up 3.72 points, 0.6%, at 683.57.

The Cboe UK 100 ended up 0.4% at 732.48, the Cboe UK 250 closed up 0.8% at 14,973.32, and the Cboe Small Companies ended up 0.3% at 12,625.27.

Stocks in New York advanced ahead of a US interest rate decision at 1800 GMT.

The Federal Reserve is widely anticipated to leave interest rates unchanged at its November meeting despite strong recent economic data.

According to the CME FedWatch Tool, there is a 98% chance the central bank will leave the federal funds rate range unchanged at 5.25% to 5.50%.

At its September meeting, the Fed left rates unchanged after hiking rates by a quarter percentage point in July.

At the time of the London close, the Dow Jones Industrial Average was up 0.2%, the S&P 500 index was up 0.5%, and the Nasdaq Composite was up 0.8%.

Craig Erlam at Oanda said: "The Fed meeting should be quite straightforward, with policymakers having come out in force to soothe market fears of another rate hike from the central bank, claiming recent moves in bond markets may have done some of the job for them.

"With no new forecasts due today, it's all about the tone from policymakers and Chair Jerome Powell, and with bond yields still near their recent highs, I see little chance of another shift."

The Bank of England will make its interest rate call tomorrow when it is expected to enact a second-successive pause and reiterate its "data dependent" outlook.

The UK central bank decided against a hike in its September meeting, maintaining bank rate at 5.25%, which is a more than 15-year high.

Deutsche Bank analyst Sanjay Raja expects the BoE to still stand pat. He predicts another vote split, however, after the doves won by a slim majority at the last meeting when five of the nine-strong Monetary Policy Committee backing the hold.

"Our base case is for 6-3 vote count in favour of keeping bank rate steady. The majority of the committee, we think, will lean on the slightly more dovish news on growth, inflation, and the labour market," Raja said.

Ahead of the meeting there was mixed economic news with a further contraction in the manufacturing sector, but a surprise rise in house prices.

The UK's manufacturing sector contracted for an eighth successive month. The S&P Global/CIPS manufacturing purchasing managers' index posted 44.8 points in October, edging up from 44.3 in September. However, the figure was worse than the previous flash estimate of 45.2.

According to S&P Global, all five sub-components of the survey signalled a deterioration in the sector.

"Alongside lower new orders, output and employment, stocks of purchases also declined and suppliers' delivery times improved (traditionally a sign of weak demand)," S&P Global said.

But UK house prices saw an unexpected rise last month, although digging beneath the headline data, economists maintained the sector is still struggling.

According to Nationwide data, on a seasonally-adjusted basis, UK house prices rose 0.9% in October from September, compared to the 0.1% rise in September from August. FXStreet-cited market consensus had expected a 0.4% decline.

Despite the rise Robert Gardner, Nationwide's chief economist, warned that housing market activity has remained "extremely weak."

The pound was quoted at USD1.2123 at the London equities close on Wednesday in London, little changed when compared to USD1.2128 on Tuesday. The euro stood at USD1.0537, down against USD1.0562. Against the yen, the dollar was trading at JPY151.07, lower compared to JPY151.63.

In European equities, the CAC 40 in Paris added 0.7%, while the DAX 40 in Frankfurt climbed 0.8%.

In the FTSE 100, Next rose 4.4% after the retailer raised its annual profit guidance by GBP10 million to GBP885 million after its third quarter sales beat expectations.

The Leicester, England-based firm said sales in the three months ended October 28 grew 4.0% from a year ago, GBP23 million ahead of its guidance which was originally set to be an increase of 2.0%. This was mainly driven by sales growth in its Online division of 6.5%.

Other retailers took heart from the statement with Marks & Spencer up 3.6% and AB Foods, the owner of Primark, rising 2.1%.

But GSK faded after a bright start to close down 2.2%. The pharmaceuticals firm hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

"Competitive performance was broadly based but benefitted particularly from the outstanding US launch of Arexvy, the world's first RSV vaccine," said Chief Executive Officer Emma Walmsley.

GSK's shingles vaccine Shingrix performed well, with sales rising 8.6% to GBP825 million from GBP760 million a year ago.

GSK also raised guidance.

It now expects turnover on a constant exchange ratio basis and excluding Covid solutions to grow between 12% and 13%, compared to a prior range of 8% to 10%. Adjusted earnings per share are set to climb 17% to 20%, upped from a previous guidance of 14% to 17%.

Elsewhere in the FTSE 100, Croda shares slipped 1.1% after Estee Lauder slashed its profit guidance blaming slow growth in Asia and disruption from the Israel-Hamas conflict.

Croda, which supplies chemical ingredients to Estee Lauder and other cosmetics brands, last month cut its profit guidance due to declining demand, especially in its North American beauty care business.

In the FTSE 250, Aston Martin went into reverse, with shares falling 11%. The luxury car manufacturer said it managed to halve its loss in the first nine months of 2023, thanks to rising orders and deliveries of its luxury cars and SUVs.

However, the Gaydon, England-based manufacturer lowered its guidance for 2023 vehicle production by about 4%.

Aston said production of its DB12 had been hit by supplier issues and the integration of its new infotainment system. It now expects to sell 6,700 models this year, down from previous guidance of 7,000.

On AIM, shares in Equals Group rose 11% after confirming that it is conducting a review of the company's strategic options.

It said it had contacted a limited number of potential counterparties to "assess whether such parties could put forward a proposal that would deliver greater value to Equals' shareholders than pursuing a standalone independent strategy."

"Any such proposal could include an offer for the entire issued and to be issued share capital of the company," it said.

Brent oil was quoted at USD86.36 a barrel at the London equities close on Wednesday, up from USD86.09 late Tuesday.

Gold was quoted at USD1,978.93 an ounce, down against USD1,989.19.

In Thursday's UK corporate calendar, telecommunications firm BT and grocer Sainsbury's report half-year results, while oil major Shell, consumer healthcare business Haleon and medical equipment maker Smith & Nephew release third quarter figures. A trading statement from gambling firm Entain is also expected.

Thursday's global economic calendar sees the UK interest rate decision at 1200 GMT and the US unemployment insurance weekly claims report at 1330 GMT.

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.